The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Long Acting Drug Delivery Market Research Report 2025
Synopsis
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The global Long Acting Drug Delivery market was valued at US$ 1536 million in 2023 and is anticipated to reach US$ 2287.8 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long Acting Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Drug Delivery.
Report Scope
The Long Acting Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Acting Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Acting Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Segment by Type
Device
Parenteral Injections
Segment by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The global Long Acting Drug Delivery market was valued at US$ 1536 million in 2023 and is anticipated to reach US$ 2287.8 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long Acting Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Drug Delivery.
Report Scope
The Long Acting Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long Acting Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long Acting Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Segment by Type
Device
Parenteral Injections
Segment by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long Acting Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Device
1.2.3 Parenteral Injections
1.3 Market by Application
1.3.1 Global Long Acting Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Clinical Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Drug Delivery Market Perspective (2019-2030)
2.2 Long Acting Drug Delivery Growth Trends by Region
2.2.1 Global Long Acting Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Long Acting Drug Delivery Market Dynamics
2.3.1 Long Acting Drug Delivery Industry Trends
2.3.2 Long Acting Drug Delivery Market Drivers
2.3.3 Long Acting Drug Delivery Market Challenges
2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Drug Delivery Players by Revenue
3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
3.4 Global Long Acting Drug Delivery Market Concentration Ratio
3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2023
3.5 Long Acting Drug Delivery Key Players Head office and Area Served
3.6 Key Players Long Acting Drug Delivery Product Solution and Service
3.7 Date of Enter into Long Acting Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Long Acting Drug Delivery Breakdown Data by Application
5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Long Acting Drug Delivery Market Size (2019-2030)
6.2 North America Long Acting Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Long Acting Drug Delivery Market Size by Country (2019-2024)
6.4 North America Long Acting Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long Acting Drug Delivery Market Size (2019-2030)
7.2 Europe Long Acting Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Long Acting Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Long Acting Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Long Acting Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long Acting Drug Delivery Market Size (2019-2030)
9.2 Latin America Long Acting Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Long Acting Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Long Acting Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Long Acting Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Detail
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2019-2024)
11.1.5 ViiV Healthcare Recent Development
11.2 Halozyme Therapeutics
11.2.1 Halozyme Therapeutics Company Detail
11.2.2 Halozyme Therapeutics Business Overview
11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024)
11.2.5 Halozyme Therapeutics Recent Development
11.3 Lubrizol Life Science
11.3.1 Lubrizol Life Science Company Detail
11.3.2 Lubrizol Life Science Business Overview
11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2019-2024)
11.3.5 Lubrizol Life Science Recent Development
11.4 Celanese Corporation
11.4.1 Celanese Corporation Company Detail
11.4.2 Celanese Corporation Business Overview
11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2019-2024)
11.4.5 Celanese Corporation Recent Development
11.5 Kashiv BioSciences
11.5.1 Kashiv BioSciences Company Detail
11.5.2 Kashiv BioSciences Business Overview
11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2019-2024)
11.5.5 Kashiv BioSciences Recent Development
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Detail
11.6.2 4P Therapeutics Business Overview
11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024)
11.6.5 4P Therapeutics Recent Development
11.7 Ipsen
11.7.1 Ipsen Company Detail
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Long Acting Drug Delivery Introduction
11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2019-2024)
11.7.5 Ipsen Recent Development
11.8 Midatech Pharma
11.8.1 Midatech Pharma Company Detail
11.8.2 Midatech Pharma Business Overview
11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2019-2024)
11.8.5 Midatech Pharma Recent Development
11.9 Re-Vana Therapeutics
11.9.1 Re-Vana Therapeutics Company Detail
11.9.2 Re-Vana Therapeutics Business Overview
11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024)
11.9.5 Re-Vana Therapeutics Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Detail
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2019-2024)
11.10.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Long Acting Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Device
Table 3. Key Players of Parenteral Injections
Table 4. Global Long Acting Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Long Acting Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Long Acting Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Long Acting Drug Delivery Market Share by Region (2019-2024)
Table 8. Global Long Acting Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Long Acting Drug Delivery Market Share by Region (2025-2030)
Table 10. Long Acting Drug Delivery Market Trends
Table 11. Long Acting Drug Delivery Market Drivers
Table 12. Long Acting Drug Delivery Market Challenges
Table 13. Long Acting Drug Delivery Market Restraints
Table 14. Global Long Acting Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Long Acting Drug Delivery Market Share by Players (2019-2024)
Table 16. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2023)
Table 17. Ranking of Global Top Long Acting Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Long Acting Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long Acting Drug Delivery Product Solution and Service
Table 21. Date of Enter into Long Acting Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long Acting Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Long Acting Drug Delivery Revenue Market Share by Type (2019-2024)
Table 25. Global Long Acting Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Long Acting Drug Delivery Revenue Market Share by Type (2025-2030)
Table 27. Global Long Acting Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Long Acting Drug Delivery Revenue Market Share by Application (2019-2024)
Table 29. Global Long Acting Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Long Acting Drug Delivery Revenue Market Share by Application (2025-2030)
Table 31. North America Long Acting Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Long Acting Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Long Acting Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Long Acting Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Long Acting Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Long Acting Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Long Acting Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Long Acting Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Long Acting Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Long Acting Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Long Acting Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Long Acting Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Long Acting Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. ViiV Healthcare Company Detail
Table 47. ViiV Healthcare Business Overview
Table 48. ViiV Healthcare Long Acting Drug Delivery Product
Table 49. ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 50. ViiV Healthcare Recent Development
Table 51. Halozyme Therapeutics Company Detail
Table 52. Halozyme Therapeutics Business Overview
Table 53. Halozyme Therapeutics Long Acting Drug Delivery Product
Table 54. Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 55. Halozyme Therapeutics Recent Development
Table 56. Lubrizol Life Science Company Detail
Table 57. Lubrizol Life Science Business Overview
Table 58. Lubrizol Life Science Long Acting Drug Delivery Product
Table 59. Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 60. Lubrizol Life Science Recent Development
Table 61. Celanese Corporation Company Detail
Table 62. Celanese Corporation Business Overview
Table 63. Celanese Corporation Long Acting Drug Delivery Product
Table 64. Celanese Corporation Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 65. Celanese Corporation Recent Development
Table 66. Kashiv BioSciences Company Detail
Table 67. Kashiv BioSciences Business Overview
Table 68. Kashiv BioSciences Long Acting Drug Delivery Product
Table 69. Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 70. Kashiv BioSciences Recent Development
Table 71. 4P Therapeutics Company Detail
Table 72. 4P Therapeutics Business Overview
Table 73. 4P Therapeutics Long Acting Drug Delivery Product
Table 74. 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 75. 4P Therapeutics Recent Development
Table 76. Ipsen Company Detail
Table 77. Ipsen Business Overview
Table 78. Ipsen Long Acting Drug Delivery Product
Table 79. Ipsen Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 80. Ipsen Recent Development
Table 81. Midatech Pharma Company Detail
Table 82. Midatech Pharma Business Overview
Table 83. Midatech Pharma Long Acting Drug Delivery Product
Table 84. Midatech Pharma Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 85. Midatech Pharma Recent Development
Table 86. Re-Vana Therapeutics Company Detail
Table 87. Re-Vana Therapeutics Business Overview
Table 88. Re-Vana Therapeutics Long Acting Drug Delivery Product
Table 89. Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 90. Re-Vana Therapeutics Recent Development
Table 91. Creative Biolabs Company Detail
Table 92. Creative Biolabs Business Overview
Table 93. Creative Biolabs Long Acting Drug Delivery Product
Table 94. Creative Biolabs Revenue in Long Acting Drug Delivery Business (2019-2024) & (US$ Million)
Table 95. Creative Biolabs Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Long Acting Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Device Features
Figure 4. Parenteral Injections Features
Figure 5. Global Long Acting Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Long Acting Drug Delivery Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Clinical Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Long Acting Drug Delivery Report Years Considered
Figure 12. Global Long Acting Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Long Acting Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Long Acting Drug Delivery Market Share by Region: 2023 VS 2030
Figure 15. Global Long Acting Drug Delivery Market Share by Players in 2023
Figure 16. Global Top Long Acting Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Drug Delivery as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2023
Figure 18. North America Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Long Acting Drug Delivery Market Share by Country (2019-2030)
Figure 20. United States Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Long Acting Drug Delivery Market Share by Country (2019-2030)
Figure 24. Germany Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Long Acting Drug Delivery Market Share by Region (2019-2030)
Figure 32. China Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Long Acting Drug Delivery Market Share by Country (2019-2030)
Figure 40. Mexico Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Long Acting Drug Delivery Market Share by Country (2019-2030)
Figure 44. Turkey Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Long Acting Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. ViiV Healthcare Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 47. Halozyme Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 48. Lubrizol Life Science Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 49. Celanese Corporation Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 50. Kashiv BioSciences Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 51. 4P Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 52. Ipsen Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 53. Midatech Pharma Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 54. Re-Vana Therapeutics Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 55. Creative Biolabs Revenue Growth Rate in Long Acting Drug Delivery Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
